MS-DRG codes

2486 MS-DRG codes with hospital pricing data in the network.

• MS-DRG 173 — Ultrasound-assisted clot-dissolving treatment for lung blood clotAI (1951 hospitals, 665–4,724 samples)
• MS-DRG 150 — Nosebleed with a major complication or comorbidityAI (2016 hospitals, 543–4,719 samples)
• MS-DRG 284 — Heart attack hospital stay ending in death, with a secondary complicating conditionAI (2016 hospitals, 495–4,671 samples)
• MS-DRG 670 — Transurethral procedure without major complications or comorbiditiesAI (2005 hospitals, 516–4,620 samples)
• MS-DRG 675 — Other kidney and urinary tract procedures without major complicationsAI (2004 hospitals, 456–4,560 samples)
• MS-DRG 965 — Hospital stay for multiple serious injuries, no major complicationsAI (2004 hospitals, 456–4,560 samples)
• MS-DRG 090 — Concussion without major or complicating conditions (hospital stay classification)AI (2004 hospitals, 681–4,542 samples)
• MS-DRG 576 — Skin graft surgery with a major complication or comorbidityAI (1973 hospitals, 1,011–4,530 samples)
• MS-DRG 182 — Lung or airway cancer hospital stay, no major complicationsAI (1981 hospitals, 831–4,494 samples)
• MS-DRG 718 — Surgery on male reproductive organs for a non-cancer condition, without major complicationsAI (1991 hospitals, 447–4,470 samples)
• MS-DRG 729 — Other male reproductive system diagnoses with complications or comorbiditiesAI (2014 hospitals, 534–4,467 samples)
• MS-DRG 802 — Surgery on blood or blood-forming organs, with a major complicating conditionAI (2000 hospitals, 437–4,370 samples)
• MS-DRG 848 — Hospital stay for chemotherapy, no acute leukemia, no major complications or comorbiditiesAI (1956 hospitals, 1,667–4,367 samples)
• MS-DRG 582 — Mastectomy for breast cancer with complications or comorbiditiesAI (1987 hospitals, 713–4,358 samples)
• MS-DRG 850 — Acute leukemia treated with other proceduresAI (1762 hospitals, 1,163–4,358 samples)
• MS-DRG 739 — Uterus and related organ surgery for non-ovarian cancer, with major complicationAI (1969 hospitals, 686–4,349 samples)
• MS-DRG 714 — Prostate surgery through the urethra, no major complicationsAI (1981 hospitals, 675–4,338 samples)
• MS-DRG 583 — Mastectomy for breast cancer without major complicationsAI (1977 hospitals, 479–4,322 samples)
• MS-DRG 869 — Hospital stay for an infectious or parasitic disease, without major complicating conditionsAI (2014 hospitals, 596–4,259 samples)
• MS-DRG 550 — Hospital stay for joint infection without major complicationsAI (2022 hospitals, 522–4,248 samples)
• MS-DRG 796 — Vaginal delivery with sterilization or D&C, with major complicationAI (1973 hospitals, 527–4,235 samples)
• MS-DRG 955 — Surgery to open the skull for multiple serious injuriesAI (1987 hospitals, 820–4,168 samples)
• MS-DRG 804 — Surgery on blood or blood-forming organs, without complicationsAI (1989 hospitals, 416–4,160 samples)
• MS-DRG 697 — Urethral stricture hospital stayAI (1993 hospitals, 414–4,140 samples)
• MS-DRG 619 — Obesity surgery with major complications or comorbiditiesAI (2001 hospitals, 520–4,138 samples)
• MS-DRG 018 — CAR T-cell and other immunotherapy treatmentAI (1889 hospitals, 802–4,132 samples)
• MS-DRG 855 — Infectious or parasitic disease treated with a surgical procedure, no major complicationsAI (1992 hospitals, 413–4,130 samples)
• MS-DRG 241 — Lower limb amputation for circulatory disorders, without complicationsAI (2002 hospitals, 528–4,119 samples)
• MS-DRG 437 — Cancer of the liver, gallbladder, or pancreas, without major complicationsAI (1988 hospitals, 746–4,076 samples)
• MS-DRG 506 — Major Thumb Or Joint ProceduresAI (1995 hospitals, 419–4,064 samples)
• MS-DRG 709 — Penis surgery with major complications or comorbiditiesAI (1981 hospitals, 406–4,060 samples)
• MS-DRG 533 — Hip or thigh bone fracture treatment with major complicationAI (2029 hospitals, 398–3,980 samples)
• MS-DRG 664 — Minor bladder procedure without complications or major complicationsAI (1996 hospitals, 394–3,940 samples)
• MS-DRG 138 — Mouth procedures without major complications or comorbiditiesAI (1969 hospitals, 743–3,920 samples)
• MS-DRG 998 — Main diagnosis on record was not accepted as valid for this stayAI (1247 hospitals, 888–3,867 samples)
• MS-DRG 198 — Interstitial lung disease, without complications or comorbiditiesAI (1993 hospitals, 506–3,854 samples)
• MS-DRG 734 — Pelvic evisceration with radical hysterectomy and vulvectomy, with complicationAI (1954 hospitals, 457–3,850 samples)
• MS-DRG 188 — Pleural effusion treatment, without complications or comorbiditiesAI (2021 hospitals, 443–3,836 samples)
• MS-DRG 715 — Surgery on male reproductive organs for cancer, with complications or major complicationsAI (1989 hospitals, 379–3,790 samples)
• MS-DRG 750 — Surgery on female reproductive organs, without major complicating conditionsAI (1977 hospitals, 1,152–3,789 samples)
• MS-DRG 078 — Hypertensive encephalopathy with complications or comorbiditiesAI (1445 hospitals, 376–3,625 samples)
• MS-DRG 416 — Gallbladder removal surgery through an open incision, without complicationsAI (2018 hospitals, 362–3,620 samples)
• MS-DRG 830 — Blood disorder or cancer procedure, no complicationsAI (1977 hospitals, 357–3,570 samples)
• MS-DRG 077 — Hospital stay for high blood pressure affecting the brain, with major complicationAI (1457 hospitals, 352–3,520 samples)
• MS-DRG 495 — Removal of internal fixation hardware from a bone, excluding hip and femur, with a major complicationAI (1997 hospitals, 352–3,520 samples)
• MS-DRG 573 — Skin graft surgery for skin ulcer or cellulitis with major complicationsAI (1984 hospitals, 427–3,514 samples)
• MS-DRG 022 — Brain blood vessel procedure for bleeding in the brain, without major complicationsAI (1954 hospitals, 350–3,500 samples)
• MS-DRG 599 — Breast cancer-related hospital stay without major complicationsAI (1925 hospitals, 2,545–3,499 samples)
• MS-DRG 650 — Kidney transplant admission with dialysis and a major complicating conditionAI (1880 hospitals, 715–3,496 samples)
• MS-DRG 320 — Heart valve procedure done through blood vessels, without major complicationsAI (1961 hospitals, 357–3,471 samples)